Free Trial

Ono Pharmaceutical (OTCMKTS:OPHLF) Shares Gap Down - What's Next?

Ono Pharmaceutical logo with Medical background

Ono Pharmaceutical Co. (OTCMKTS:OPHLF - Get Free Report)'s share price gapped down prior to trading on Wednesday . The stock had previously closed at $10.71, but opened at $9.33. Ono Pharmaceutical shares last traded at $9.33, with a volume of 108 shares changing hands.

Ono Pharmaceutical Price Performance

The stock has a fifty day moving average of $10.99 and a 200-day moving average of $10.58. The company has a quick ratio of 2.56, a current ratio of 3.07 and a debt-to-equity ratio of 0.13. The firm has a market capitalization of $4.38 billion, a P/E ratio of 13.33 and a beta of 0.52.

Ono Pharmaceutical Company Profile

(Get Free Report)

Ono Pharmaceutical Co, Ltd., together with its subsidiaries, produces, purchases, and sells pharmaceuticals and diagnostic reagents worldwide. It offers Opdivo Intravenous Infusion and Kyprolis Intravenous Injection for malignant tumors; Emend capsules/Proemend intravenous injections for chemotherapy-induced nausea and vomiting; Demser capsules for the symptoms in patients with pheochromocytoma; and Mektovi, Velexbru, and Braftovi capsules for malignant tumors, as well as ADLUMIZ tablets for cancer cachexia.

See Also

Should You Invest $1,000 in Ono Pharmaceutical Right Now?

Before you consider Ono Pharmaceutical, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Ono Pharmaceutical wasn't on the list.

While Ono Pharmaceutical currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It
NVDA Greenlight: China Sales Spark 50% Rally Potential

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines